Antiemetic Prophylaxis With Fosaprepitant and Ondansetron in Patients Undergoing Thoracic Surgery
Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare the efficacy, safety and feasibility of
intravenous Fosaprepitant and Ondansetron for the prevention of postoperative nausea and
vomiting in thoracicsurgery patients. Participants will be randomized in a 1:1 ratio to the
Fosaprepitant and Ondansetron group.The groups were analyzed and compared for frequency of
vomiting in 24 h after surgery. In addition, we will further compare the occurrence of
postoperative pulmonary complications, length of hospital stay, nutrition and quality of life
after surgery in patients treated with different antiemetic prophylaxis.